In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lee's Pharmaceutical Holdings Ltd.

www.leespharm.com

Latest From Lee's Pharmaceutical Holdings Ltd.

Monumental Year Ahead For Korean Pharmas As New US Approvals Eyed

2019 could be a monumental year for the South Korean pharma industry, as several new drug assets await the green light from the US FDA.
South Korea Outlook 2019

Asia Deal Watch: Boost For Esperion's Cholesterol Candidate As Daiichi Brought On Board

Daiichi Sankyo pays $150m upfront to commercialize Esperion's cholesterol drug and combination in Europe, while Gilead enters major deal worth up to $785m with Korea's Yuhan to bolster its NASH portfolio. Samsung taps 3SBio to build its biosimilars business in China. 
Deals Asia Pacific

Transgene Hopes To Finally Catch The Wave In Virus Based Immunotherapies

Transgene's CEO discusses its immunotherapy pipeline, coming catalysts, and why the French biotech may soon be swept up by growing interest in oncolytic viruses.

Clinical Trials Companies

Korea Stepping Up IO R&D To Catch Up With Global Players, Trends

Immuno-oncology deals and R&D by South Korean companies are picking up speed as they are put more focus on the hot sector in line with global trends.

Commercial ImmunoOncology
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Dermatology
  • Gynecological, Urological
  • Infectious & Viral Diseases
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Hong Kong
  • Parent & Subsidiaries
  • Lee's Pharmaceutical Holdings Ltd.
  • Senior Management
  • Xiaoyi Li, CEO
  • Contact Info
  • Lee's Pharmaceutical Holdings Ltd.
    Phone: (852) 2314 1282
    1/F, Building 20E, Phase 3
    Shatin,
    Hong Kong
Advertisement
Advertisement
UsernamePublicRestriction

Register